Image

Global Narcolepsy Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Narcolepsy Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Narcolepsy Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2858.56 Million
Diagram Market Size (Forecast Year) USD 6353.98 Million
Diagram CAGR %

Global Narcolepsy Treatment Market, By Type (Type 1 Narcolepsy, Type 2 Narcolepsy), Drugs (Selective Histamine H3-Receptor Antagonist, Stimulants, Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Central Nervous System Depressant, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) - Industry Trends and Forecast to 2030.

Narcolepsy Treatment Market

Narcolepsy Treatment Market Analysis and Size

The global narcolepsy treatment market is rising steadily as a result of the rising prevalence of narcolepsy and rising healthcare expenditure. Growing R&D activities is considerably driving the global narcolepsy treatment market. Strategic initiatives by the key market players are one of the elements driving the market's rapid rise. Market players are expanding their product offerings to acquire a competitive advantage.

Data Bridge Market Research analyses that the global narcolepsy treatment market which was USD 2,858.56 Million in 2022, would rocket up to USD 6,353.98 Million by 2030, and is expected to undergo a CAGR of 10.5% during the forecast period. This indicates the market value. “Handheld instruments” dominates the product segment of the global narcolepsy treatment market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Narcolepsy Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Type (Type 1 Narcolepsy, Type 2 Narcolepsy), Drugs (Selective Histamine H3-Receptor Antagonist, Stimulants, Serotonin Reuptake Inhibitors, Tricyclic antidepressant, Central Nervous System Depressant, Others), Route of Administration (Oral, Injectable), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

Avadel (Ireland), Vallon Pharmaceuticals (U.S.), Jazz Pharmaceuticals, Inc.(Ireland), Jubilant Pharmova Limited (India), BIOPROJET (France), Hikma Pharmaceuticals PLC (UK), Amneal Pharmaceuticals LLC (U.S.), Teva Pharmaceutical Industries Ltd (Ireland), Ligand Pharmaceuticals Incorporated (U.S.), Novartis AG (Switzerland), Mylan N.V.(U.S.), Alkem Labs (India), Alembic Pharmaceuticals Limited (India), Torrent Pharmaceuticals Ltd (India), Johnson & Johnson Private Limited (U.S.), F. Hoffmann-La Roche Ltd.(Switzerland), Zydus Cadila (India)

Market Opportunities

  • Growing demand in emerging market
  • Penetration of new technologies
  • Rising prevalence of Narcolepsy

Market Definition

The global narcolepsy treatment market refers to the pharmaceutical and therapeutic interventions, products, and services used for the management and treatment of narcolepsy, a neurological sleep disorder characterized by excessive daytime sleepiness, sudden loss of muscle tone (cataplexy), hallucinations, and disrupted night sleep patterns.

The market includes various treatment options aimed at reducing the symptoms associated with narcolepsy and improving the overall quality of life for affected individuals. These treatment modalities can include medications, such as stimulants, antidepressant, and sodium oxybate, as well as lifestyle modifications, behavioral therapies, and supportive care.

Global Narcolepsy Treatment Market Dynamics

Drivers

  • Increasing Prevalence of Narcolepsy

The rising incidence and prevalence of narcolepsy globally are driving the demand for effective treatment options. The growing recognition of narcolepsy as a neurological disorder has led to increased diagnosis and treatment-seeking behaviour.

  • Technological Advancements in Diagnosis

Advancements in diagnostic techniques, such as polysomnography, multiple sleep latency tests, and genetic testing, have improved the accuracy and efficiency of narcolepsy diagnosis. This has facilitated early intervention and treatment, thereby driving market growth.

Opportunities

  • Technological Innovations

Advancements in drug delivery systems, digital health technologies, and telemedicine present opportunities to enhance narcolepsy treatment. Innovations such as wearable devices for symptom monitoring and telemedicine platforms for remote consultations can improve access and patient outcomes.

Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising number of market players will further expand the market's growth rate in the future. 

Restraint/Challenge

  • High cost associated with the product manufacturing

The high cost associated with the product manufacturing is expected to obstruct market growth. Also, the disruption in the supply chain industry has the potential to challenge the market’s growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.

This Global Narcolepsy Treatment Market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Narcolepsy Treatment Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • Jazz Pharmaceuticals is a leading player in the narcolepsy treatment market. They market Xyrem (sodium oxybate), an FDA-approved medication for cataplexy and excessive daytime sleepiness in narcolepsy patients
  • In 2020, Jazz Pharmaceuticals acquired Cavion, Inc., a clinical-stage biotechnology company focused on developing therapies for neurological diseases, including narcolepsy. This acquisition expanded Jazz Pharmaceuticals' pipeline of potential narcolepsy treatments.

Global Narcolepsy Treatment Market Scope

The global narcolepsy treatment market is segmented on the basis of type, drugs, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Type 1 Narcolepsy
  • Type 2 Narcolepsy

Drugs

  • Selective Histamine H3-Receptor Antagonist
  • Stimulants
  • Serotonin Reuptake Inhibitors
  • Tricyclic Antidepressants
  • Central Nervous System Depressant
  • Others

Route of Administration

  • Oral
  • Injectable

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Global Narcolepsy Treatment Market Regional Analysis/Insights

Global narcolepsy treatment market is analyzed, and market size insights and trends are provided by type, drugs, route of administration, end-users, and distribution channel as referenced above.

The countries covered in the global narcolepsy treatment market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.

North America dominates the market due to factors including rising healthcare costs, increased R & D and trending technological advancements.

Asia-Pacific is expected to witness the fastest growth during the forecast period of 2023 to 2030 because of the rising strategic initiatives by the key market players and favourable government initiatives in the region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Narcolepsy Treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Narcolepsy Treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Narcolepsy Treatment market. The data is available for historic period 2015-2021

Competitive Landscape and Narcolepsy Treatment Market Share Analysis

The Narcolepsy Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Narcolepsy Treatment market.

Some of the major players operating in the Narcolepsy Treatment market are:

  • Avadel (Ireland)
  • Vallon Pharmaceuticals (U.S.)
  • Jazz Pharmaceuticals, Inc.(Ireland)
  • Jubilant Pharmova Limited (India)
  • BIOPROJET (France)
  • Hikma Pharmaceuticals PLC (UK)
  • Amneal Pharmaceuticals LLC (U.S.)
  • Teva Pharmaceutical Industries Ltd (Ireland)
  • Ligand Pharmaceuticals Incorporated (U.S.)
  • Novartis AG (Switzerland)
  • Mylan N.V.(U.S.)
  • Alkem Labs (India)
  • Alembic Pharmaceuticals Limited (India)
  • Torrent Pharmaceuticals Ltd (India)
  • Johnson & Johnson Private Limited (U.S.)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Zydus Cadila (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Narcolepsy Treatment Market will be worth USD 6,353.98 Million by 2030.
The Narcolepsy Treatment Market Growth Rate is 10.5% during the forecast period.
The Technological Advancements in Diagnosis and Increasing Prevalence of Narcolepsy are the Growth Drivers of the Narcolepsy Treatment Market.
Type, drugs, route of administration, end-users, and distribution channel are the factors on which the Narcolepsy Treatment Market research is based.
Jazz Pharmaceuticals acquired Cavion, Inc., a clinical-stage biotechnology company focused on developing therapies for neurological diseases, including narcolepsy and Jazz Pharmaceuticals is a leading player in the narcolepsy treatment market. They market Xyrem (sodium oxybate), an FDA-approved medication for cataplexy and excessive daytime sleepiness in narcolepsy patients are the latest developments in the Narcolepsy Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials